Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeanette Lechner-Scott

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Multiple Sclerosis and Related Disorders|December 1, 2023
Is multiple sclerosis a glymphaticopathy?Alaa A Alghanimy, Gavin Giovannoni, Jeanette Lechner-Scott, et al.
Case Reports in Neurology|June 1, 2017
Favourable Outcome in a 33-Year-Old Female with Acute Haemorrhagic LeukoencephalitisWaldo G Solis, Sophie E Waller, Angela K Harris, et al.
Multiple Sclerosis and Related Disorders|April 22, 2020
The future of microbiome research in neuroinflammatory disordersEmmanuelle Waubant, Anne-Katrin Pröbstel, Michael Levy, et al.
Neurology and Therapy|June 10, 2026
Summary of Research: Cognition and Employment Status of People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Two-Year CLARIFY-MS StudyBruno Brochet, Dawn Langdon, Eva Kubala Havrdova, et al.
Multiple Sclerosis and Related Disorders|June 1, 2020
The MSReactor computerized cognitive battery correlates with the processing speed test in relapsing-remitting multiple sclerosisCharmaine Yam, Daniel Merlo, Jim Stankovich, et al.
Neurology and Therapy|March 10, 2026
Stability in Cognition and Employment in People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Two-year Phase IV CLARIFY-MS StudyBruno Brochet, Dawn Langdon, Eva Kubala Havrdova, et al.
Neurology and Therapy|June 1, 2026
Correction: Stability in Cognition and Employment in People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Two‑year Phase IV CLARIFY‑MS StudyBruno Brochet, Dawn Langdon, Eva Kubala Havrdova, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 13, 2022
Long-term trajectories of employment status, workhours and disability support pension status, after a first episode of CNS demyelinationAmin Zarghami, Ingrid van der Mei, Mohammad Akhtar Hussain, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 4, 2024
Long-term disability trajectories in multiple sclerosis: a group-based trajectory analysis of the AusLong cohortAmin Zarghami, Mohammad Akhtar Hussain, Ingrid van der Mei, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 6, 2023
A pro-inflammatory diet in people with multiple sclerosis is associated with an increased rate of relapse and increased FLAIR lesion volume on MRI in early multiple sclerosis: A prospective cohort studyAlice M Saul, Bruce V Taylor, Leigh Blizzard, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Multiple Sclerosis and Related Disorders|December 1, 2023
Is multiple sclerosis a glymphaticopathy?Alaa A Alghanimy, Gavin Giovannoni, Jeanette Lechner-Scott, et al.
Case Reports in Neurology|June 1, 2017
Favourable Outcome in a 33-Year-Old Female with Acute Haemorrhagic LeukoencephalitisWaldo G Solis, Sophie E Waller, Angela K Harris, et al.
Multiple Sclerosis and Related Disorders|April 22, 2020
The future of microbiome research in neuroinflammatory disordersEmmanuelle Waubant, Anne-Katrin Pröbstel, Michael Levy, et al.
Neurology and Therapy|June 10, 2026
Summary of Research: Cognition and Employment Status of People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Two-Year CLARIFY-MS StudyBruno Brochet, Dawn Langdon, Eva Kubala Havrdova, et al.
Multiple Sclerosis and Related Disorders|June 1, 2020
The MSReactor computerized cognitive battery correlates with the processing speed test in relapsing-remitting multiple sclerosisCharmaine Yam, Daniel Merlo, Jim Stankovich, et al.
Neurology and Therapy|March 10, 2026
Stability in Cognition and Employment in People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Two-year Phase IV CLARIFY-MS StudyBruno Brochet, Dawn Langdon, Eva Kubala Havrdova, et al.
Neurology and Therapy|June 1, 2026
Correction: Stability in Cognition and Employment in People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Two‑year Phase IV CLARIFY‑MS StudyBruno Brochet, Dawn Langdon, Eva Kubala Havrdova, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 13, 2022
Long-term trajectories of employment status, workhours and disability support pension status, after a first episode of CNS demyelinationAmin Zarghami, Ingrid van der Mei, Mohammad Akhtar Hussain, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 4, 2024
Long-term disability trajectories in multiple sclerosis: a group-based trajectory analysis of the AusLong cohortAmin Zarghami, Mohammad Akhtar Hussain, Ingrid van der Mei, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 6, 2023
A pro-inflammatory diet in people with multiple sclerosis is associated with an increased rate of relapse and increased FLAIR lesion volume on MRI in early multiple sclerosis: A prospective cohort studyAlice M Saul, Bruce V Taylor, Leigh Blizzard, et al.
Pageof 5